Genetic Technologies (GENE) Institutional Ownership $0.76 0.00 (0.00%) (As of 12/20/2024 ET) Add Compare Share Share Ownership Stock AnalysisChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Genetic Technologies (NASDAQ:GENE)CurrentInstitutional OwnershipPercentage0.63%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$236.30KNumber ofInstitutional Sellers(last 12 months)0 Get GENE Insider Trade Alerts Want to know when executives and insiders are buying or selling Genetic Technologies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data GENE Institutional Buying and Selling by Quarter Ad Crypto 101 MediaDeFi Coin on Verge of Breakout!The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Claim your FREE book now before it's too late! Genetic Technologies Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2024 Armistice Capital LLC140,000$210K0.0%N/A3.177% 5/1/2024 BNP Paribas Financial Markets9,100$26K0.0%N/A0.236% 11/7/2023 Scarborough Advisors LLC548,372$417K0.0%+5,054.8%2.850% 3/6/2023 OLD Mission Capital LLC70,241$65K0.0%+109.7%0.365% 11/22/2022 Continental Investors Services Inc.32,000$47K0.0%N/A0.208% 11/14/2022 OLD Mission Capital LLC33,499$39K0.0%N/A0.218% 8/13/2021 Jump Financial LLC10,657$45K0.0%N/A0.069% 8/11/2021Susquehanna Fundamental Investments LLC36,172$154K0.0%-44.0%0.235% 5/17/2021 Hennion & Walsh Asset Management Inc.10,072$42K0.0%N/A0.067% 5/17/2021 Goldman Sachs Group Inc.21,602$90K0.0%N/A0.144% 2/12/2021Credit Suisse AG20,836$75K0.0%N/A0.139% 12/11/2020 Virtu Financial LLC23,954$83K0.0%+35.4%0.177% 11/13/2020 Morgan Stanley10,447$36K0.0%+109.1%0.077% (Data available from 1/1/2016 forward) GENE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of GENE shares? During the previous two years, the following institutional investors and hedge funds held shares of Genetic Technologies shares: Scarborough Advisors LLC ($417K), Armistice Capital LLC ($210K), and OLD Mission Capital LLC ($65K), BNP Paribas Financial Markets ($26K).Learn more on GENE's institutional investors. What percentage of Genetic Technologies stock is owned by institutional investors? 0.63% of Genetic Technologies stock is owned by institutional investors. Learn more on GENE's institutional investor holdings. Which institutional investors have been buying Genetic Technologies stock? The following institutional investors have purchased Genetic Technologies stock in the last 24 months: Scarborough Advisors LLC ($537.73K), Armistice Capital LLC ($140K), OLD Mission Capital LLC ($36.74K), and BNP Paribas Financial Markets ($9.10K). How much institutional buying is happening at Genetic Technologies? Institutional investors have bought a total of 723,576 shares in the last 24 months. This purchase volume represents approximately $2.46M in transactions. Related Companies HCWB Major Shareholders MRNS Major Shareholders PMCB Major Shareholders AWH Major Shareholders SLGL Major Shareholders IPA Major Shareholders KZIA Major Shareholders CRVO Major Shareholders RLMD Major Shareholders KPRX Major Shareholders This page (NASDAQ:GENE) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredTech funds are hemorrhaging cash: Sell this stock nowSomething very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genetic Technologies Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Genetic Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GENE Stock Alerts